Alltrna
The world’s first transfer RNA (tRNA) platform company. We are unlocking the vast therapeutic potential within #tRNA.
49 employees · est. 2018 · Cambridge, United States
Lexeo Therapeutics
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer's disease areas.
97 employees · est. 2018 · New York, United States
Lexeo Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Alltrna | Lexeo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | Cambridge, United States | New York, United States |
| Employees | ||
| Employees | 49 | 97 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $159.00M | $280.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Development of tRNA-based therapies, Engineering programmable tRNAs, Restoration of protein production, Treatment for stop codon diseases, Scaling genetic medicine | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with rare genetic diseases, Medical research communities, Healthcare providers, Biopharmaceutical companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Therapeutics, TRNA Biology, Genetic Mutations, Protein Production, Rare Diseases, Common Diseases, Machine Learning Tools, Flagship Labs, Startup, Innovation, Biomedical Research, Precision Medicine, Genomics | Genetic Medicine, Clinical-stage, Gene Therapy, Rare Diseases, Cardiovascular Diseases, Alzheimer's Disease, AAV-mediated Therapies, Weill Cornell Medicine, University Of California San Diego, New York City, Research Collaboration, Commercialization, Preclinical Pipeline, Innovation |
| Website | ||
| Website | alltrna.com | lexeotx.com |
About Alltrna
Alltrna, founded in 2018 at Flagship Labs, is pioneering the use of transfer RNA (tRNA) to unlock vast therapeutic potentials in the field of biotechnology and health care. As the world’s first tRNA platform company, its mission is to advance tRNA therapeutics that can regulate the protein universe...
About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based biotechnology startup that is making waves in the field of genetic medicines. The company is on a mission to revolutionize healthcare by leveraging cutting-edge science to change the way diseases are treated. Its focus areas include cardiovascular and APOE...
We will tell you when either one moves
BounceWatch watches Alltrna and Lexeo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alltrna and Lexeo Therapeutics — by email.
Frequently Asked Questions
Compare Alltrna with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Alltrna on 9 Jun 2026, and Lexeo Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.